These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24763694)

  • 21. Epistatic roles for Pseudomonas aeruginosa MutS and DinB (DNA Pol IV) in coping with reactive oxygen species-induced DNA damage.
    Sanders LH; Devadoss B; Raja GV; O'Connor J; Su S; Wozniak DJ; Hassett DJ; Berdis AJ; Sutton MD
    PLoS One; 2011 Apr; 6(4):e18824. PubMed ID: 21533111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of Pseudomonas aeruginosa into the alginate-producing form: inactivation of mucB causes conversion to mucoidy.
    Martin DW; Schurr MJ; Mudd MH; Deretic V
    Mol Microbiol; 1993 Aug; 9(3):497-506. PubMed ID: 8412698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of AlgU, a member of the sigma E-like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis.
    Schurr MJ; Yu H; Martinez-Salazar JM; Boucher JC; Deretic V
    J Bacteriol; 1996 Aug; 178(16):4997-5004. PubMed ID: 8759866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin-Derived C-Terminal Filaggrin-2 Fragments Are Pseudomonas aeruginosa-Directed Antimicrobials Targeting Bacterial Replication.
    Hansmann B; Schröder JM; Gerstel U
    PLoS Pathog; 2015 Sep; 11(9):e1005159. PubMed ID: 26371476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the hypervirulent Pseudomonas aeruginosa strain LESB58.
    Wnorowska U; Niemirowicz K; Myint M; Diamond SL; Wróblewska M; Savage PB; Janmey PA; Bucki R
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3808-15. PubMed ID: 25870055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human host defense peptide LL-37 stimulates virulence factor production and adaptive resistance in Pseudomonas aeruginosa.
    Strempel N; Neidig A; Nusser M; Geffers R; Vieillard J; Lesouhaitier O; Brenner-Weiss G; Overhage J
    PLoS One; 2013; 8(12):e82240. PubMed ID: 24349231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium.
    Barlow PG; Beaumont PE; Cosseau C; Mackellar A; Wilkinson TS; Hancock RE; Haslett C; Govan JR; Simpson AJ; Davidson DJ
    Am J Respir Cell Mol Biol; 2010 Dec; 43(6):692-702. PubMed ID: 20097832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The YfiBNR signal transduction mechanism reveals novel targets for the evolution of persistent Pseudomonas aeruginosa in cystic fibrosis airways.
    Malone JG; Jaeger T; Manfredi P; Dötsch A; Blanka A; Bos R; Cornelis GR; Häussler S; Jenal U
    PLoS Pathog; 2012; 8(6):e1002760. PubMed ID: 22719254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway.
    Hoffman LR; Richardson AR; Houston LS; Kulasekara HD; Martens-Habbena W; Klausen M; Burns JL; Stahl DA; Hassett DJ; Fang FC; Miller SI
    PLoS Pathog; 2010 Jan; 6(1):e1000712. PubMed ID: 20072604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases.
    Sol A; Skvirsky Y; Nashef R; Zelentsova K; Burstyn-Cohen T; Blotnick E; Muhlrad A; Bachrach G
    J Biol Chem; 2014 Aug; 289(33):22926-22941. PubMed ID: 24947511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sigma factor-anti-sigma factor interaction in alginate synthesis: inhibition of AlgT by MucA.
    Xie ZD; Hershberger CD; Shankar S; Ye RW; Chakrabarty AM
    J Bacteriol; 1996 Aug; 178(16):4990-6. PubMed ID: 8759865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional equivalence of Escherichia coli sigma E and Pseudomonas aeruginosa AlgU: E. coli rpoE restores mucoidy and reduces sensitivity to reactive oxygen intermediates in algU mutants of P. aeruginosa.
    Yu H; Schurr MJ; Deretic V
    J Bacteriol; 1995 Jun; 177(11):3259-68. PubMed ID: 7768826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epoxide-mediated CifR repression of cif gene expression utilizes two binding sites in Pseudomonas aeruginosa.
    Ballok AE; Bahl CD; Dolben EL; Lindsay AK; St Laurent JD; Hogan DA; Madden DR; O'Toole GA
    J Bacteriol; 2012 Oct; 194(19):5315-24. PubMed ID: 22843844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo.
    Scott A; Weldon S; Buchanan PJ; Schock B; Ernst RK; McAuley DF; Tunney MM; Irwin CR; Elborn JS; Taggart CC
    PLoS One; 2011; 6(10):e26525. PubMed ID: 22028895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa.
    Qiu D; Eisinger VM; Head NE; Pier GB; Yu HD
    Microbiology (Reading); 2008 Jul; 154(Pt 7):2119-2130. PubMed ID: 18599839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene cluster controlling conversion to alginate-overproducing phenotype in Pseudomonas aeruginosa: functional analysis in a heterologous host and role in the instability of mucoidy.
    Schurr MJ; Martin DW; Mudd MH; Deretic V
    J Bacteriol; 1994 Jun; 176(11):3375-82. PubMed ID: 8195094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa.
    Cirioni O; Ghiselli R; Tomasinsig L; Orlando F; Silvestri C; Skerlavaj B; Riva A; Rocchi M; Saba V; Zanetti M; Scalise G; Giacometti A
    Shock; 2008 Oct; 30(4):443-8. PubMed ID: 18391859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different mutations in mucA gene of Pseudomonas aeruginosa mucoid strains in cystic fibrosis patients and their effect on algU gene expression.
    Pulcrano G; Iula DV; Raia V; Rossano F; Catania MR
    New Microbiol; 2012 Jul; 35(3):295-305. PubMed ID: 22842599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression.
    Hoffman LR; Kulasekara HD; Emerson J; Houston LS; Burns JL; Ramsey BW; Miller SI
    J Cyst Fibros; 2009 Jan; 8(1):66-70. PubMed ID: 18974024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.
    Geitani R; Ayoub Moubareck C; Touqui L; Karam Sarkis D
    BMC Microbiol; 2019 Mar; 19(1):54. PubMed ID: 30849936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.